← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Recombinetics, Inc.
Eagan, MN
$13,770,992
Total funding
21
Grants
Funding over time
peak $3M · FY2011–24$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$13,770,992 · 21
By mechanism
R43$5,841,696 · 17
U24$4,136,179 · 1
R44$3,474,915 · 2
R41$318,202 · 1
Investigators at Recombinetics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Modeling Disease in Swine by Transplantation of Gene Targeted Germ Cells$1,010,357
R44 · FY2019 · GM
Modeling Disease in Swine by Transplantation of Gene Targeted Germ Cells$986,749
R44 · FY2018 · GM
Development of Swine Reporter Models for Testing Somatic Cell Genome Editing Tools$812,036
U24 · FY2020 · OD
Development of Swine Reporter Models for Testing Somatic Cell Genome Editing Tools$800,133
U24 · FY2019 · OD
Development of Swine Reporter Models for Testing Somatic Cell Genome Editing Tools$799,513
U24 · FY2018 · OD
Development of Swine Reporter Models for Testing Somatic Cell Genome Editing Tools$781,473
U24 · FY2021 · OD
Development of Swine Reporter Models for Testing Somatic Cell Genome Editing Tools$777,054
U24 · FY2022 · OD
Development of a porcine model of polycystic kidney disease by multiplex gene-editing.$749,640
R44 · FY2017 · DK
Development of a porcine model of polycystic kidney disease by multiplex gene-editing.$728,169
R44 · FY2018 · DK
Development and Evaluation of a Thrombospondin 2 Deficient Pig as an Improved Source of Biomaterial$398,952
R43 · FY2019 · HL
Development of a genetic swine model of non-alcoholic steatohepatitis (NASH) by gene-editing$398,884
R43 · FY2017 · OD
Development of swine model of COPD by integrating genetic and environmental risk factors$398,696
R43 · FY2017 · OD
Generating a Porcine Model for Human Microvillus Inclusion Disease (MVID) by Gene Editing$394,730
R43 · FY2016 · DK
Gene Therapy for MPS IV A in a Novel Porcine Model of the Disease$384,999
R43 · FY2024 · AR
Development and maintenance of T, B and NK-cell deficient swine by multiplex gene-editing and immune restoration$376,083
R43 · FY2015 · HL
Modeling disease in swine by transplantation of gene targeted germ cells.$375,429
R43 · FY2014 · GM
A Humanized Swine Model for Alzheimer's Disease$358,338
R43 · FY2016 · AG
Development and Characterization of a Swine Model of Phenylketonuria$355,198
R43 · FY2016 · OD
Development of a porcine model of polycystic kidney disease by multiplex gene-editing.$352,419
R43 · FY2014 · DK
Development and Characterization of a Swine Model of Neurofibromatosis Type 2$347,891
R43 · FY2016 · NS